Long-Term Thesis

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Long-Term Thesis in One Page

The long-term thesis: MICC compounds into the only listed pure-play global ice cream business by closing a structural margin gap to private peer Froneri while an AMEA emerging-market engine — already at 22.9% Adjusted EBITDA margin and 10.9% organic growth — drags the consolidated mix toward staples-peer profitability over 5-to-10 years. Three things must become true together for a long-duration compounder outcome: the $771M FY25 gap between Adjusted EBITDA and IFRS operating profit collapses by FY27 as Transitional Service Agreements end, AMEA revenue mix rises from ~24% toward 30%+ while preserving its EM margin signature, and the 3-million-cabinet fleet keeps earning a returns premium that competitors cannot replicate at any price. The category is durable — 5%-CAGR global ice cream, 1-3 litres per capita penetration in large emerging markets versus 7-11 in the West — but TMICC's claim to be the long-term winner rests on management proving, for the first time outside Unilever, that the brand IP and cabinet moat earn above-peer through a cycle, not just in one segment. The bear's structural ammunition (peer-trailing reported margin, $495-525M of FY26 adjustments still guided, 19.85% Unilever overhang) is observable today; the bull's case rests on a 2028 $0.93-1.17B free cash flow bridge that must clear two reporting cycles. Verdict: High-conviction on category, Medium-conviction on durability, Medium-conviction on the standalone management execution that turns category into shareholder return.

The 5-to-10-Year Underwriting Map

Driver #1 — AMEA mix-shift — matters most. The other six drivers either denominate or facilitate it: cabinet reinvestment funds AMEA's cold-chain advantage, productivity savings amplify AMEA's margin pull-up, and the carve-out cushion is the noise that obscures it on the reported income statement today. If AMEA fails to compound at its current cadence, the consolidated margin walk is left to Europe and Americas alone — and those segments have lost share over the past decade. The whole 5-to-10-year case for buying MICC instead of Unilever, Nestlé, or General Mills rests on AMEA mathematically dragging the group profile toward an EM consumer compounder while the rest of the portfolio is restructured.

Compounding Path

The compounding math here is mechanical rather than aspirational: organic sales growth at the mid-point of management's 3-5% range, ~50bps of annual Adjusted EBITDA margin expansion, and capex held near 5% of revenue creates the bridge from $1,475M FY25 Adj EBITDA to ~$1.69B FY27 and a $0.93-1.17B free cash flow run-rate by 2028. The risk is not whether the math works — it is whether each lever lands at the same time, because cocoa, EM FX, and Unilever placement supply can each individually push out the timeline by a year.

Growth: FY25 OSG of 4.2% and Q1 FY26 OSG of 4.5% sit at the middle of the 3-5% algorithm; AMEA is doing 10.9% OSG on a 24%-of-group base. Margin: the 40-60bps walk is the entire bull case and depends on AMEA mix (~10bps per pp of mix), productivity ($294M cumulative to date of $583M target), and pricing/mix discipline elsewhere. Cash conversion: FY25's $45M reported FCF is distorted by the one-time $1,063M inventory subsidy payable to Unilever; ex-separation comparable FCF was $707M. Reinvestment: capex at 4.5% of revenue is well below historical Unilever-stewardship lows (sub-3%) and is now directed at cabinets and AMEA factory builds. Balance sheet: pre-spin $273M net debt has become $3,486M post-spin at 2.4× Adj EBITDA, but IG ratings hold and the $1.17B RCF is undrawn — room exists for bolt-on acquisitions or a step-up in cabinet capex without re-rating the credit.

Durability and Moat Tests

The competitive tests (1, 2, 4) and the financial tests (3, 5) point at the same question from opposite ends: does the moat that is visible in AMEA and in cabinet density show up in the consolidated margin line that an investor actually owns? Ten years of share loss inside Unilever (2013-2023) is the strongest piece of evidence that the moat has not historically converted to durable returns. Two consecutive years of share gain (FY24, FY25) and the largest capex step-up in a decade are the strongest pieces of evidence that the standalone entity can break the pattern. Either way, the answer arrives in the FY27 reported margin and the FY27 adjusting-items line — not in any single quarter.

Management and Capital Allocation Over a Cycle

The pre-demerger track record is the bear case: a decade of share loss (2013-2023), profitability "flat for a 10-year period," capex held below 3% of turnover, peak-summer service levels at 80%, and a Beauty Foods diversification that the same CEO now publicly disavows ("a shame that we pulled out by choice"). That history is the reason the cabinet moat and brand IP did not earn an above-peer return through the last full cycle, and it is the reason the bull case has to argue that something has structurally changed since March 2024.

The standalone track record is short but the pattern matters more than its length. Around 85% of top leaders are new in role (per AR), the productivity programme banked $294M of its $583M cumulative target at the half-way mark, volume growth was restored from negative through 2.9% in Q1 FY26, and the demerger itself was executed cleanly with a 7× oversubscribed bond and investment-grade ratings of BBB / Baa2. Six of nine short-cycle promises made at the September 2025 Capital Markets Day have been kept; three (margin algorithm, 2028 FCF, dividend policy) remain pending and will be tested over FY26-FY28.

Alignment is genuine on the executive side and weaker at board level. CEO Peter ter Kulve has $6.93M of personal cash in stock at 476% of base salary (target 500%); CFO Abhijit Bhattacharya has $2.40M at 235% of base (target 400%); CEO variable comp is 70% of total. Dutch statutory clawback runs five years and there is a two-year post-cessation hold. Against that, the FY25 short-term bonus paid 95% of target while GAAP net income fell 48% and headline FCF fell 95% — a discretionary 125% multiplier on a 76% formulaic outcome. The 2024 Replacement PSP vests at 100% with no real test. Unilever retains 19.85% ($2,294M) and one Non-Executive Director, Reginaldo Ecclissato, is a sitting Unilever Leadership Executive serving on TMICC's Nomination and Governance Committee. 22.63% of shareholders voted against the Foundation Plan at the May 2026 AGM.

The net assessment is that management is more likely to improve the long-term thesis than to impair it, but with two specific governance concerns to monitor: the discretionary bonus multiplier (whether it persists in FY26 if results miss) and Unilever's placement discipline (whether the 19.85% block is sold in a way that respects retained-shareholder returns). Neither is a thesis-killer; both are reasons not to underwrite an above-trend rerate purely on incentive design.

Failure Modes

The two High-severity failure modes are not independent. If the Adjusted-items cushion is structural (#1), AMEA is the only place left where the moat earns its keep; if AMEA mix-shift fails (#2), the cushion has to compress for the consolidated picture to look like anything other than a low-margin staple. Either failure alone leaves the thesis intact; both together would break it.

What To Watch Over Years, Not Just Quarters

The long-term thesis changes most if the FY27 Adjusting-items disclosure lands below $235M with a single consolidated FCF presentation — that one annual print collapses the structural-versus-transitional cushion debate, validates the bridge to $0.93-1.17B 2028 FCF, and is the gate through which every other long-term signal (AMEA mix, margin convergence, cabinet returns, Unilever placement) must pass to matter.